| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/30/2009 | US20090191610 Microorganisms With Increased Efficiency for Methionine Synthesis |
| 07/30/2009 | US20090191606 Organic compounds |
| 07/30/2009 | US20090191605 Ketoreductase Polypeptides for the Reduction of Acetophenones |
| 07/30/2009 | US20090191600 Via L-aspartic acid- alpha,beta-diester and L-phenylalanine using enzyme that has ability to selectively link L-phenylalanine to alpha -ester site of L-aspartic acid- alpha,beta-diester through peptide bond/nucleophilic attack; easy, high yield and inexpensively without going through a complex synthesis |
| 07/30/2009 | US20090191591 Taurine Transporter Gene |
| 07/30/2009 | US20090191590 Signal Peptide for Producing a Polypeptide |
| 07/30/2009 | US20090191589 Process for producing dipeptides |
| 07/30/2009 | US20090191588 Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav |
| 07/30/2009 | US20090191587 Method for high-level secretory production of protein |
| 07/30/2009 | US20090191578 Canis sphingosine 1-phosphate receptor isoform 5 |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |
| 07/30/2009 | US20090191569 Mammalian Cytokines; Related Reagents |
| 07/30/2009 | US20090191555 HCV NS3-NS4 Protease Resistance Mutants |
| 07/30/2009 | US20090191552 Novel Human Acidic Mammalian Chitinase and Use Thereof |
| 07/30/2009 | US20090191550 Diagnosis of whipple's disease |
| 07/30/2009 | US20090191539 Primers for isothermal amplification of hepatitis C virus |
| 07/30/2009 | US20090191536 Rabbit monoclonal antibodies to hepatitis B surface antigens and methods of using the same |
| 07/30/2009 | US20090191292 High essential oil and eugenol yielding cultivar of ocimum sanctum 'CIM-AYU' |
| 07/30/2009 | US20090191263 Compositions and methods for sirna inhibition of hif-1 alpha |
| 07/30/2009 | US20090191261 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 07/30/2009 | US20090191255 Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders |
| 07/30/2009 | US20090191241 Method and compositions for immunization with the pseudomonas v antigen |
| 07/30/2009 | US20090191240 Flavivirus Vaccines |
| 07/30/2009 | US20090191239 Recombinant infectious laryngotracheitis virus and uses thereof |
| 07/30/2009 | US20090191237 Methods and reagents for vaccination which generate A CD8 T cell immune response |
| 07/30/2009 | US20090191236 comprises claimed amino acid sequence or an immunogenic fragment thereof wherein the protein elicits production of antibodies that interfere with invasion by Babesia bovis into erythrocytes |
| 07/30/2009 | US20090191235 Conformationally stabilized hiv envelope immunogens and triggering hiv-1 envelope to reveal cryptic v3-loop epitopes |
| 07/30/2009 | US20090191234 Vaccine |
| 07/30/2009 | US20090191231 Prevention and treatment of amyloidogenic disease |
| 07/30/2009 | US20090191222 Metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression |
| 07/30/2009 | US20090191221 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same |
| 07/30/2009 | US20090191216 Antibody or a fragment thereof, having neutralizing activity against HIV |
| 07/30/2009 | US20090191211 METHODS FOR DAMAGING CELLS USING EFFECTOR FUNCTIONS OF ANTI-EphA4 ANTIBODIES |
| 07/30/2009 | US20090191210 Method for inhibiting tumor invasion or spreading in a subject |
| 07/30/2009 | US20090191209 Methods and compositions for targeting polyubiquitin |
| 07/30/2009 | US20090191206 Human Semen Enhancer of Viral Infection Peptides (SEVI) and Their Use |
| 07/30/2009 | US20090191204 Anti-psgl-1 antibodies |
| 07/30/2009 | US20090191203 Bcma Polypeptides And Uses Thereof |
| 07/30/2009 | US20090191192 Humanized anti-ccr2 antibodies and methods of use therefor |
| 07/30/2009 | US20090191190 Anti-ABeta Globulomer Antibodies, Antigen-Binding Moieties Thereof, Corresponding Hybridomas, Nucleic Acids, Vectors, Host Cells, Methods of Producing Said Antibodies, Compositions Comprising Said Antibodies, Uses Of Said Antibodies And Methods Of Using Said Antibodies |
| 07/30/2009 | US20090191189 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
| 07/30/2009 | US20090191187 Antibodies against interleukin-1 receptor and uses thereof |
| 07/30/2009 | US20090191182 Compositions, Kits, and Methods for the Modulation of Immune Responses Using Galectin-1 |
| 07/30/2009 | US20090191171 Reprogramming of Differentiated Progenitor or Somatic Cells Using Homologous Recombination |
| 07/30/2009 | US20090191170 Nucleic acid compositions and methods of introducing nucleic acids into cells |
| 07/30/2009 | US20090191166 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
| 07/30/2009 | US20090191155 Usher 1B syndrome ocular disease; delivering subretinally to target cells; expression vehicle is HIV-1; CMV-MYO7A promoter or promoter active in photoreceptor or retinal pigment epithelium (RPE) cell; polynucleotide sequence encoding myosin VIIA; chromosomal integration sequence; gene therapy; blindness |
| 07/30/2009 | US20090191146 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/30/2009 | US20090191133 Modulation of stat 6 expression for the treatment of airway hyperresponsiveness |
| 07/30/2009 | US20090191117 Anti-Integrin Antibodies, Compositions, Methods and Uses |
| 07/30/2009 | US20090188793 Method of Error Reduction in Nucleic Acid Populations |
| 07/30/2009 | DE102008006101A1 Preparing erythrulose, useful e.g. in cosmetics as self-tanning lotion, comprises incubating erythrite-containing output substrate with an erythrulose-tolerant microorganism of the species Gluconobacter and extracting erythrulose |
| 07/30/2009 | CA2713120A1 Transcriptional activators involved in abiotic stress tolerance |
| 07/30/2009 | CA2712802A1 Compositions and methods for detecting juvenile renal dysplasia or calcium oxalate stones in dogs |
| 07/30/2009 | CA2712779A1 Methods and organisms for utilizing synthesis gas or other gaseous carbon sources and methanol |
| 07/30/2009 | CA2712567A1 Plants having enhanced yield-related traits and a method for making the same |
| 07/30/2009 | CA2712221A1 Humanized antibodies specific for von willebrand factor |
| 07/30/2009 | CA2709804A1 Enhanced protein production in bacillus |
| 07/30/2009 | CA2708279A1 Thermal and acid tolerant beta-xylosidases, genes encoding, related organisms, and methods |
| 07/29/2009 | EP2083367A1 Method for prediction of higher-order nucleic acid structure, apparatus for prediction of higher-order nucleic acid structure, and program for prediction of higher-order nucleic acid structure |
| 07/29/2009 | EP2083272A1 Cancer cell identification marker and cancer cell proliferation inhibitor |
| 07/29/2009 | EP2083271A2 Composite arrays |
| 07/29/2009 | EP2083269A1 Method of assaying target substance in sample, aptamer molecule and method of constructing the same |
| 07/29/2009 | EP2083267A1 Diagnosis and treatment of autism using cd38 |
| 07/29/2009 | EP2083090A1 Nucleic acid interaction analysis |
| 07/29/2009 | EP2083089A1 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
| 07/29/2009 | EP2083087A1 Method for determining tongue cancer |
| 07/29/2009 | EP2083085A1 Screening method for therapeutic agent for amyotrophic lateral sclerosis |
| 07/29/2009 | EP2083084A1 Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
| 07/29/2009 | EP2083083A1 Method for production of l-amino acid |
| 07/29/2009 | EP2083082A1 Overproduction of vitamin B6 in plants |
| 07/29/2009 | EP2083081A1 Compositions and methods of treating disease with FGFR fusion proteins |
| 07/29/2009 | EP2083080A1 Process for the preparation of l-amino acids using strains of the Enterobacteriaceae family which contain an enhanced rseA or rseC gene |
| 07/29/2009 | EP2083079A1 Apo-2DcR |
| 07/29/2009 | EP2083078A1 Method of evaluating drug sensitivity by analyzing the mu-opioid receptor gene |
| 07/29/2009 | EP2083077A1 Method of evaluating drug sensitivity by analyzing the mu-opioid receptor gene |
| 07/29/2009 | EP2083076A1 In vitro differentiation/induction of lymphocyte from stem cell having genotype provided after gene reconstitution |
| 07/29/2009 | EP2083075A1 Process for conversion of germplasm |
| 07/29/2009 | EP2083074A1 Modified flavine-adenine-dinucleotide-dependent glucose dehydrogenase |
| 07/29/2009 | EP2083073A1 Reagent containing fused protein of soluble rankl with epitope tag |
| 07/29/2009 | EP2083072A1 Stem-regulated, plant defense promotor and uses thereof in tissue-specific expression in monocots |
| 07/29/2009 | EP2083070A1 Microorganism capable of controlling plant diseases and plant disease-controlling agent using the microorganism |
| 07/29/2009 | EP2083018A2 Compositions and methods relating to STOP-1 |
| 07/29/2009 | EP2083017A1 Antibody having enhanced adcc activity and method for production thereof |
| 07/29/2009 | EP2083016A1 Bacterial superantigen vaccines |
| 07/29/2009 | EP2082750A1 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
| 07/29/2009 | EP2082749A2 Prevention and treatment of Alzheimer's disease |
| 07/29/2009 | EP2082237A2 Means and methods for isolating and determining novel targets for the treatment of neurodegenerative, neurological or neuropsychiatric disorders and compositions comprising the same |
| 07/29/2009 | EP2082225A1 Assay |
| 07/29/2009 | EP2082052A2 Knockout mice for pro1105, pro1279 or pro1783 coding genes |
| 07/29/2009 | EP2082051A1 Methods and means for removal of a selected dna sequence |
| 07/29/2009 | EP2082050A2 Delta-8 desaturases and their use in making polyunsaturated fatty acids |
| 07/29/2009 | EP2082049A1 Plants having enhanced yield-related traits and a method for making the same using consensus sequences from the yabby protein family |
| 07/29/2009 | EP2082048A2 The maize erecta genes for improving plant growth, transpiration efficiency and drought tolerance in crop plants |
| 07/29/2009 | EP2082047A2 Compositions and methods for improved protein production |
| 07/29/2009 | EP2082046A2 Improved production of secreted proteins by filamentous fungi |
| 07/29/2009 | EP2082045A1 Method of reducing gene expression using modified codon usage |
| 07/29/2009 | EP2082044A1 Method of increasing gene expression using modified codon usage |
| 07/29/2009 | EP2082043A1 Expression vectors with improved safety |